CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.Bruce Ruggeri, Craig A. Dionne, Diane E. Gingrich et al.|PubMed|2003Cited by 124
Neurotrophic 3,9-Bis[(alkylthio)methyl]- and -Bis(alkoxymethyl)-K-252a DerivativesMasami Kaneko, Chikara Murakata, Yutaka Saito et al.|Journal of Medicinal Chemistry|1997Cited by 120
Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitorsThelma S. Angeles, Robert L. Hudkins|Expert Opinion on Drug Discovery|2016Cited by 113
Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cellsWeihua Wan, Mangeng Cheng, Mark S. Albom et al.|Blood|2005Cited by 105
Mixed lineage kinase activity of indolocarbazole analoguesChikara Murakata, Robert L. Hudkins, Masami Kaneko et al.|Bioorganic & Medicinal Chemistry Letters|2002Cited by 94